House GOP Probes DEA Fentanyl 'Walk' Policy

House Republicans have launched an investigation into a controversial Drug Enforcement Administration (DEA) strategy. The tactic involved monitoring major fentanyl shipments without seizing them, allowing the drugs to reach communities while authorities built criminal cases.

Congressional Inquiry and Legal Action

This congressional inquiry, led by House Oversight Committee Chairman Rep. James Comer (R-Ky.), follows a lawsuit filed by New Mexico Attorney General Raúl Torrez. Both actions seek records related to the DEA's decisions. The source of this information is a report from the Associated Press. Officials in New Mexico, described as the epicenter of the fentanyl crisis, have raised alarms. DEA whistleblowers recently reported being ordered not to seize hundreds of thousands of fentanyl pills. This alleged inaction may violate Justice Department rules designed to protect communities. Attorney General Torrez sued the Justice Department last week, aiming to force the release of records.

Details of the 'Walk' Strategy

In a letter to Attorney General Todd Blanche, Rep. Comer criticized the policy. He stated that while DEA agents may not have the resources to intercept every single known shipment, a policy directing them not to intercept significant shipments is unconscionable and undoubtedly resulted in considerable harm and lives lost. The investigative method, known as allowing drugs to 'walk,' was detailed in an Associated Press investigation. It found DEA agents repeatedly monitored major fentanyl shipments in New Mexico between 2023 and 2025 without intervention. The White House last year designated the synthetic opioid a 'weapon of mass destruction.'

Policy Changes and Broader Review

The strategy continued into the Trump administration's second term, involving a relaxation of fentanyl risk mitigation protocols developed during President Donald Trump's first term. An earlier policy from 2017 instructed agents to seize or otherwise prevent the distribution of fentanyl as soon as practicable. The Justice Department rewrote those rules in 2024. The new guidelines gave law enforcement far more discretion on whether to act to prevent trafficking, citing the benefits to be achieved through preserving the investigation. The Justice Department's internal watchdog announced a nationwide review this month. A spokesperson said their investigations are long term and complex and done under the guidance of the law, and they need to stay 100% focused on the adversary. The DEA did not immediately respond to the committee's request for comment.